about
Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerModeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCsSite-directed Mutagenesis (Y52E) of POLH Affects Its Ability to Bypass Ultraviolet-induced DNA Lesions in HaCaT CellsPredominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells.Cooperative motion of a key positively charged residue and metal ions for DNA replication catalyzed by human DNA Polymerase-η.Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents.Current advances in DNA repair: regulation of enzymes and pathways involved in maintaining genomic stability.
P2860
Q34849073-182F5E67-B128-4D95-BEFE-3B906B67E48AQ35923231-2C00B0AD-4D95-4671-BF82-C1E8105A3189Q36330854-C78B0DB7-3A85-4114-B8CF-5FC5A476CA57Q38717184-9FD885B0-D8C5-40CA-B458-651416441A89Q39951181-160416A2-1E07-4701-8083-11E4F519909EQ41093149-C992A02B-ED38-413D-9846-17017D37E350Q42735393-D427AC81-AD94-4F84-B365-8DCB6F0240ED
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA polymerase eta and chemotherapeutic agents.
@en
DNA polymerase eta and chemotherapeutic agents.
@nl
type
label
DNA polymerase eta and chemotherapeutic agents.
@en
DNA polymerase eta and chemotherapeutic agents.
@nl
prefLabel
DNA polymerase eta and chemotherapeutic agents.
@en
DNA polymerase eta and chemotherapeutic agents.
@nl
P2860
P356
P1476
DNA polymerase eta and chemotherapeutic agents.
@en
P2093
Kai-ming Chou
P2860
P304
P356
10.1089/ARS.2010.3673
P577
2011-03-18T00:00:00Z